NDA 019970 · Baxter Hlthcare
Nitroglycerin In Dextrose 5%
Nitroglycerin · Injection · Nitrate Vasodilator
Last checked: Nov 20, 2026Latest source record: Aug 22, 2016 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
1989
Dec 29, 1989
Approved uses
1
Original approval plus efficacy supplements
Registered trials
237
47 Phase 3, 10 recruiting
FAERS reports
40,398
32,851 serious, 5,402 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
From the label in effect Dec 18, 2025.
INDICATIONS AND USAGE Nitroglycerin in 5% Dextrose Injection is indicated for treatment of peri-operative hypertension; for control of heart failure in the setting of acute myocardial infarction; for treatment of angina pectoris in patients who have not responded to sublingual nitroglycerin and ß-blockers; and for induction of intraoperative hypotension.
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
- Dec 29, 1989 Original approval · Type 3 - New Dosage Form
3 products under this application
- NITROGLYCERIN IN DEXTROSE 5% · NITROGLYCERIN 20MG/100ML · INJECTABLE, INJECTION · Prescription · TE AP
- NITROGLYCERIN IN DEXTROSE 5% · NITROGLYCERIN 40MG/100ML · INJECTABLE, INJECTION · Prescription · TE AP
- NITROGLYCERIN IN DEXTROSE 5% · NITROGLYCERIN 10MG/100ML · INJECTABLE, INJECTION · Prescription · TE AP
Clinical trials
Interventional ClinicalTrials.gov studies with "Nitroglycerin" as an intervention, any sponsor and status, largest first.
- Enhanced Control of Hypertension and Thrombolysis Stroke Study (ENCHANTED)Pivotal-lookingCompleted
The George InstituteAcademic, hospital or other
NCT01422616 · 4,587 participants · Start Mar 2012 · Primary completion Aug 2018
Drug: Low-dose rtPA; Standard-dose rtPA · For: Ischemic Stroke; High Blood Pressure
Sites: Sydney, Australia
- The Efficacy of Nitric Oxide in Stroke (ENOS) TrialPivotal-lookingStatus unknown
University of NottinghamAcademic, hospital or other
NCT00989716 · 3,500 participants (planned) · Start Jul 2001 · Primary completion Oct 2013
Drug: Transdermal glyceryl trinitrate patch; Pre-stroke antihypertensives · For: Stroke
Sites: Nottingham, United Kingdom
- Topical Nitroglycerin To Prevent Radial Artery Occlusion After Transradial Access: NTP-RAO TrialPivotal-lookingStatus unknown
Total Cardiovascular SolutionsAcademic, hospital or other
NCT02413268 · 2,400 participants (planned) · Start Mar 2016 · Primary completion Jul 2020
Drug: Nitroglycerin · For: Total Atherosclerotic Occlusion of Radial Artery
Sites: Ahmedabad, India
- Prevention of Radial Artery Occlusion After Transradial Access Using NitroglycerinPivotal-lookingCompleted
Instituto de Cardiologia de Santa CatarinaAcademic, hospital or other
NCT03158532 · 2,040 participants · Start Jul 6, 2017 · Primary completion Oct 1, 2021
Drug: Nitroglycerin I; Placebo I and 2 more · For: Injury of Radial Artery
Sites: Florianópolis, Brazil; São Jose, Brazil; Marília, Brazil
- Nitroglycerin Prevents Radial Artery OcclusionPivotal-lookingCompleted
National Cardiovascular Center Harapan Kita Hospital IndonesiaAcademic, hospital or other
NCT02105493 · 1,706 participants · Start Oct 2013 · Primary completion Feb 2014
Drug: 500 microgram of Nitroglycerin; Saline 5 mL · For: Injury of Radial Artery
Sites: Jakarta, Indonesia
- Does Glyceryl Nitrate Prevent Post-Endoscopic Retrograde Cholangiopancreaticography (ERCP) Pancreatitis?Pivotal-lookingCompleted
Hvidovre University HospitalAcademic, hospital or other
NCT00121901 · 1,600 participants (planned) · Start Oct 2004
Drug: glyceryl nitrate · For: Pancreatitis
Sites: Copenhagen, Denmark; Køge, Denmark; Odense, Denmark · 14 sites in all
- Subcutaneous Nitroglycerin to Facilitate Trans-radial Access.Pivotal-lookingSuspended
Instituto Nacional de Cardiologia Ignacio ChavezAcademic, hospital or other
NCT03304496 · 1,400 participants (planned) · Start Mar 30, 2018 · Primary completion Mar 30, 2019
Drug: Nitroglycerin 100 MCG/ML Injectable Solution; Saline Solution · For: Coronary Artery Disease
Sites: Mexico City, Mexico
- GOT-IT Trial: Glyceryl Trinitrate for Retained PlacentaPivotal-lookingCompleted
University of EdinburghAcademic, hospital or other
NCT02085213 · 1,107 participants · Start Sep 2014 · Primary completion Jul 26, 2017
Drug: Glyceryl Trinitrate; Matched Placebo · For: Placenta, Retained
Sites: Edinburgh, United Kingdom
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
- dyspnoea3,466
- pain3,149
- fatigue2,783
- myocardial infarction2,706
- nausea2,666
- fall2,439
- chest pain2,400
- dizziness2,392
- drug ineffective2,367
- headache2,197
- diarrhoea2,135
- hypotension2,026
FAERS reports by year
By the date FDA received the report.
View as table
| Year | Reports |
|---|---|
| 2004 | 946 |
| 2005 | 1,063 |
| 2006 | 899 |
| 2007 | 676 |
| 2008 | 900 |
| 2009 | 1,201 |
| 2010 | 1,366 |
| 2011 | 2,238 |
| 2012 | 1,664 |
| 2013 | 816 |
| 2014 | 2,369 |
| 2015 | 1,411 |
| 2016 | 1,613 |
| 2017 | 1,694 |
| 2018 | 2,072 |
| 2019 | 2,228 |
| 2020 | 2,076 |
| 2021 | 2,216 |
| 2022 | 2,851 |
| 2023 | 2,837 |
| 2024 | 2,792 |
| 2025 | 2,688 |
| 2026 | 1,778 |
Recalls
1 FDA enforcement reports for this application.
Nov 18, 2013 · Class I · Terminated
Presence of Particulate Matter; particulate matter in one vial identified as silicone rubber and EPDM rubber from the vial stopper.
Shortages
FDA's drug shortage list.
Not on FDA's shortage list.
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- Local nitroglycerin to facilitate peripheral arterial cannulation in children: systematic review and meta-analysis.
Wagh D, Pawale D, Tan JKG, et al. · Arch Dis Child 2022 · Meta-Analysis, Systematic Review
- Cardiac Rehabilitation Improves Endothelial Function in Coronary Artery Disease Patients.
Manresa-Rocamora A, Ribeiro F, Casanova-Lizón A, et al. · Int J Sports Med 2022 · Meta-Analysis, Systematic Review
- Perioperative diltiazem or nitroglycerin in on-pump coronary artery bypass: A systematic review and network meta-analysis.
Hu Y, Yang X, Zhang L, et al. · PLoS One 2018 · Systematic Review, Network Meta-Analysis
- The efficacy of nitroglycerin to prevent radial artery spasm and occlusion during and after transradial catheterization: A systematic review and meta-analysis of randomized controlled trials.
Abdelazeem B, Abuelazm MT, Swed S, et al. · Clin Cardiol 2022 · Meta-Analysis, Systematic Review
- Subcutaneous Nitroglycerin to Prevent Radial Artery Occlusion in Pediatric Patients: A Randomized Clinical Trial.
Park JB, Ji SH, Kim EH, et al. · JAMA Pediatr 2025 · Randomized Controlled Trial
- Efficacy and safety of topical nitroglycerin in the prevention of mastectomy flap necrosis: a systematic review and meta-analysis.
Wang P, Gu L, Qin Z, et al. · Sci Rep 2020 · Meta-Analysis, Research Support, Non-U.S. Gov't
Sponsor: Baxter Hlthcare
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.